Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Gland Pharma Ltd. ( (IN:GLAND) ) is now available.
Gland Pharma has initiated a postal ballot process seeking shareholder approval to reappoint Ms. Naina Lal Kidwai as an independent director and to authorize payment of commission on profits as part of her remuneration. The company is conducting the exercise exclusively through remote e-voting in line with Indian corporate governance and regulatory requirements, with voting open from April 14 to May 13, 2026, and results to be declared on or before May 15, 2026.
More about Gland Pharma Ltd.
Gland Pharma Ltd. is an India-based pharmaceutical company focused on manufacturing and supplying injectable formulations. It operates in the regulated markets, serving domestic and international customers with a range of sterile products, and is listed on both BSE and NSE in India.
Average Trading Volume: 15,674
Technical Sentiment Signal: Sell
Current Market Cap: 286.7B INR
For an in-depth examination of GLAND stock, go to TipRanks’ Overview page.